[go: up one dir, main page]

ZA979175B - Novel piperidineketocarboxylic acid derivatives their preparation and use - Google Patents

Novel piperidineketocarboxylic acid derivatives their preparation and use

Info

Publication number
ZA979175B
ZA979175B ZA979175A ZA979175A ZA979175B ZA 979175 B ZA979175 B ZA 979175B ZA 979175 A ZA979175 A ZA 979175A ZA 979175 A ZA979175 A ZA 979175A ZA 979175 B ZA979175 B ZA 979175B
Authority
ZA
South Africa
Prior art keywords
piperidineketocarboxylic
novel
preparation
acid derivatives
derivatives
Prior art date
Application number
ZA979175A
Other languages
English (en)
Inventor
Wilfried Lubisch
Achim Moeller
Juergen DELZER
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA979175B publication Critical patent/ZA979175B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA979175A 1996-10-15 1997-10-14 Novel piperidineketocarboxylic acid derivatives their preparation and use ZA979175B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19642591A DE19642591A1 (de) 1996-10-15 1996-10-15 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung

Publications (1)

Publication Number Publication Date
ZA979175B true ZA979175B (en) 1999-04-14

Family

ID=7808858

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA979175A ZA979175B (en) 1996-10-15 1997-10-14 Novel piperidineketocarboxylic acid derivatives their preparation and use

Country Status (24)

Country Link
US (1) US6380220B1 (ru)
EP (1) EP0934273A1 (ru)
JP (1) JP2001501955A (ru)
KR (1) KR20000049130A (ru)
CN (1) CN1239950A (ru)
AR (1) AR009379A1 (ru)
AU (1) AU736754B2 (ru)
BG (1) BG103338A (ru)
BR (1) BR9711908A (ru)
CA (1) CA2268917A1 (ru)
CO (1) CO4930264A1 (ru)
CZ (1) CZ126899A3 (ru)
DE (1) DE19642591A1 (ru)
HR (1) HRP970549A2 (ru)
HU (1) HUP9904104A3 (ru)
IL (1) IL129089A0 (ru)
NO (1) NO991761D0 (ru)
NZ (1) NZ334979A (ru)
PL (1) PL332720A1 (ru)
RU (1) RU2189974C2 (ru)
SK (1) SK38599A3 (ru)
TR (1) TR199900819T2 (ru)
WO (1) WO1998016512A1 (ru)
ZA (1) ZA979175B (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306505A (zh) * 1998-04-20 2001-08-01 Basf公司 新的取代酰胺、其制备以及应用
DE19817459A1 (de) * 1998-04-20 1999-10-21 Basf Ag Neue heterozyklische substituierte Amide, Herstellung und Anwendung
PL343495A1 (en) 1998-04-20 2001-08-27 Basf Ag Heterocyclically substituted amides used as calpain inhibitors
TR200003071T2 (tr) * 1998-04-20 2001-04-20 Basf Aktiengesellschaft Sistein-proteazı önleyici etkiye sahip yeni heterosiklik ikame edilmiş amidler
US6117870A (en) * 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
AU6936500A (en) * 1999-08-24 2001-03-19 Regents Of The University Of California, The Non-quinoline inhibitors of malaria parasites
CZ20011872A3 (cs) 1999-09-29 2002-03-13 Ortho-Mcneil Pharmaceutical, Inc. Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
WO2002002546A1 (en) 2000-06-30 2002-01-10 Seikagaku Corporation EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM
DE10114762A1 (de) * 2001-03-26 2002-10-02 Knoll Gmbh Verwendung von Cysteinprotease-Inhibitoren
JP2004529918A (ja) 2001-04-09 2004-09-30 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド インテグリンに由来する疾患の治療のためのキナゾリンおよびキナゾリン類似化合物
AU2003267991B2 (en) 2002-07-11 2009-10-08 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
WO2005016883A2 (en) * 2003-08-14 2005-02-24 Icos Corporation Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
AU2004284089B2 (en) * 2003-10-24 2009-11-26 Aventis Pharmaceuticals Inc. Novel keto-oxadiazole derivatives as cathepsin inhibitors
PT2439205E (pt) 2006-12-29 2015-07-16 Abbvie Deutschland Compostos de carboxamida e seus usos como inibidores de calpaína
TWI453019B (zh) 2007-12-28 2014-09-21 Abbvie Deutschland 甲醯胺化合物
TWI519530B (zh) 2009-02-20 2016-02-01 艾伯維德國有限及兩合公司 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
US9051304B2 (en) 2009-12-22 2015-06-09 AbbVie Deutschland GmbH & Co. KG Carboxamide compounds and their use as calpain inhibitors V
US8598211B2 (en) 2009-12-22 2013-12-03 Abbvie Inc. Carboxamide compounds and their use as calpain inhibitors IV
WO2012076639A1 (en) 2010-12-09 2012-06-14 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors v
EP2834230A1 (en) 2012-04-03 2015-02-11 AbbVie Deutschland GmbH & Co KG Carboxamide compounds and their use as calpain inhibitors v
WO2017156071A1 (en) 2016-03-09 2017-09-14 Blade Therapeutics, Inc. Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
AU2017292646A1 (en) 2016-07-05 2019-02-07 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
WO2018064119A1 (en) 2016-09-28 2018-04-05 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
AU2018278422B2 (en) 2017-06-01 2022-03-17 Eisai R&D Management Co., Ltd. Lewy body disease therapeutic agent containing pyrazoloquinoline derivative
KR20200010211A (ko) 2017-06-01 2020-01-30 에자이 알앤드디 매니지먼트 가부시키가이샤 Pde9 저해제를 포함하는 약제학적 조성물
US20210009564A1 (en) * 2018-03-28 2021-01-14 Blade Therapertics, Inc. Calpain modulators and therapeutic uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
CA2098609A1 (en) 1990-12-28 1992-06-29 Raymond T. Bartus Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
JPH06504547A (ja) * 1990-12-28 1994-05-26 ジョージア・テック・リサーチ・コーポレーション ペプチドケトアミド、ケト酸およびケトエステル
CA2071621C (en) * 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
WO1994000095A2 (en) * 1992-06-24 1994-01-06 Cortex Pharmaceuticals, Inc. Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
US5541290A (en) * 1993-06-24 1996-07-30 Harbeson; Scott L. Optically pure calpain inhibitor compounds

Also Published As

Publication number Publication date
EP0934273A1 (de) 1999-08-11
AR009379A1 (es) 2000-04-12
CA2268917A1 (en) 1998-04-23
AU736754B2 (en) 2001-08-02
AU4777097A (en) 1998-05-11
BR9711908A (pt) 1999-08-24
NO991761L (no) 1999-04-14
HUP9904104A3 (en) 2001-01-29
KR20000049130A (ko) 2000-07-25
RU2189974C2 (ru) 2002-09-27
BG103338A (bg) 2000-01-31
CO4930264A1 (es) 2000-06-27
CN1239950A (zh) 1999-12-29
IL129089A0 (en) 2000-02-17
DE19642591A1 (de) 1998-04-16
NO991761D0 (no) 1999-04-14
PL332720A1 (en) 1999-10-11
SK38599A3 (en) 2000-04-10
JP2001501955A (ja) 2001-02-13
CZ126899A3 (cs) 1999-07-14
HRP970549A2 (en) 1998-08-31
WO1998016512A1 (de) 1998-04-23
TR199900819T2 (xx) 1999-06-21
US6380220B1 (en) 2002-04-30
NZ334979A (en) 2001-02-23
HUP9904104A2 (hu) 2000-05-28

Similar Documents

Publication Publication Date Title
ZA979175B (en) Novel piperidineketocarboxylic acid derivatives their preparation and use
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
IL126638A0 (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
ZA982478B (en) Compounds their use and preparation
IL116139A0 (en) Pyrrole derivatives their preparation and use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
ZA973097B (en) Novel aspire-hydroxy acid derivatives their preparation and use
IL123611A0 (en) Novel amino acid derivatives their preparation and use
IL126476A0 (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
IL116525A0 (en) Piperazinedione derivatives their preparation and use
ZA973098B (en) Novel carboxylic acid derivatives their preparation and use
EG21121A (en) 13 Substituted milbemycin derivatives their preparation and use
IL126026A0 (en) Novel carboxylic acid derivatives their preparation and their use
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
IL121691A0 (en) N-benzylazolium derivatives their preparation and compositions containing them
ZA932576B (en) 1,2,4-benzothiadiazine-3-carboxylic acid derivatives, their preparation and their use
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use